To Be Discontinued Injection Endocrinology/Metabolism
Somatropin Injection · 301 days since initial FDA posting
Brand: NORDITROPIN
FDA lists Somatropin Injection as To Be Discontinued (Novo Nordisk, Inc.).
No availability text on this FDA row.
Somatropin Injection: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Somatropin Injection
- Manufacturer
- Novo Nordisk, Inc.
- Dosage Form
- Injection
- Presentation
- Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21)
- Package NDC
- 0169-7703-21
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Nov 14, 2025
- Last Updated
- Nov 14, 2025
- Therapeutic Category
- Endocrinology/Metabolism
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.